Google Inc (GOOG): These Hedge Funds Are Getting Killed Right Now

Google Inc (NASDAQ:GOOG)‘s shares are down close to 9% after the tech giant released it’s third quarter earnings midday, wherein it was expected to release them after the closing bell. Trading has since been halted, but that hasn’t stopped speculation on what exactly happened. While we’ll leave the conjecture up to the reader, the miss was notable, as analysts were expecting it to reach EPS of $10.65 a share; Google Inc (NASDAQ:GOOG) reached just $9.03 a share. The miss of more than 15% comes after Google Inc (NASDAQ:GOOG) beat earnings estimates in Q1 and Q2 by an average margin of 2.3%.

In the hedge fund industry, Google Inc (NASDAQ:GOOG) is a widely loved stock; it had returned over 17% year to date before the surprising miss. As noted in “5 Stocks Billionaires are Crazy About“, Google is the second most popular stock among hedge funds second to Apple. Let’s take a quick look at the top five funds (by value) with a position in the tech giant.

LONE PINE CAPITAL

Stephen Mandel’s Lone Pine Capital

Shares of Google Inc (NASDAQ:GOOG): 1,335,321

Value: $774.6 million

Activity Last Quarter: +2%

Percentage of Portfolio: 4.6%

Paul Ruddock and Steve Heinz’s Lansdowne Partners

Shares of Google: 918,388

Value: $532.7 million

Activity Last Quarter: +40%

Percentage of Portfolio: 9.7%

Chase Coleman’s Tiger Global Management

Shares of Google: 904,000

Value: $524.4 million

Activity Last Quarter: -3%

Percentage of Portfolio: 8.8%

Philippe Laffont’s Coatue Management

Shares of Google: 729,566

Value: $423.2 million

Activity Last Quarter: -3%

Percentage of Portfolio: 8.0%

Ken Fisher’s Fisher Asset Management*

Shares of Google Inc (NASDAQ:GOOG): 722,999

Value: $419.4 million

Activity Last Quarter: +2%

Percentage of Portfolio: 1.2%

Disclosure: I have no positions in Google Inc (GOOG) and no plans to initiate any positions within the next 72 hours.

*Ken Fisher’s Fisher Asset Management is not a hedge fund; it is technically classified as an independent investment advisory firm.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!